Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-008207
Filing Date
2012-02-07
Accepted
2012-02-07 17:22:49
Documents
1
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 4078
  Complete submission text file 0001209191-12-008207.txt   5590
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 6035 STONERIDGE DRIVE PLEASANTON CA 94588
Business Address
Smith David V (Reporting) CIK: 0001229447 (see all company filings)

Type: 5 | Act: 34 | File No.: 033-80623 | Film No.: 12578807